107 related articles for article (PubMed ID: 8907572)
1. Regulation of atrial natriuretic factor receptors in portal hypertensive rabbits.
Cahill PA; Redmond EM; Wu Y; Sitzmann JV
J Hepatol; 1996 Feb; 24(2):185-93. PubMed ID: 8907572
[TBL] [Abstract][Full Text] [Related]
2. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats.
Cahill PA; Redmond EM; Hodges R; Zhang S; Sitzmann JV
J Hepatol; 1996 Sep; 25(3):370-8. PubMed ID: 8895017
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide in portal vein-ligated rats: alterations in cardiac production, plasma level and glomerular receptor density and affinity.
Jonas GM; Morgan TR; Morgan K; Thillainadarajah I; Hornacek C
Hepatology; 1992 Apr; 15(4):696-701. PubMed ID: 1312988
[TBL] [Abstract][Full Text] [Related]
4. Enhanced nitric oxide synthase activity in portal hypertensive rabbits.
Cahill PA; Foster C; Redmond EM; Gingalewski C; Wu Y; Sitzmann JV
Hepatology; 1995 Aug; 22(2):598-606. PubMed ID: 7543437
[TBL] [Abstract][Full Text] [Related]
5. Loss of angiotensin-II receptors in portal hypertensive rabbits.
Sitzmann JV; Wu Y; Aguilera G; Cahill PA; Burns RC
Hepatology; 1995 Aug; 22(2):559-64. PubMed ID: 7635425
[TBL] [Abstract][Full Text] [Related]
6. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
[TBL] [Abstract][Full Text] [Related]
9. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
Wu Y; Burns RC; Sitzmann JV
Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
[TBL] [Abstract][Full Text] [Related]
11. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
12. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.
Cahill PA; Wu Y; Sitzmann JV
J Clin Invest; 1994 Jun; 93(6):2691-700. PubMed ID: 8201006
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
Imura R; Sano T; Goto J; Yamada K; Matsuda Y
Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
[TBL] [Abstract][Full Text] [Related]
14. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
16. Localization of atrial natriuretic factor receptors in the mesenteric arterial bed. Comparison with angiotensin II and endothelin receptors.
De León H; Bonhomme MC; Thibault G; Garcia R
Circ Res; 1995 Jul; 77(1):64-72. PubMed ID: 7788883
[TBL] [Abstract][Full Text] [Related]
17. Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats.
Schiffrin EL; Parent A; St Louis J; Tremblay J; Garcia R; Thibault G
Cardiovasc Res; 1992 Sep; 26(9):857-64. PubMed ID: 1360334
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis.
Moreau R; Tazi KA; Komeichi H; Pussard E; Lebrec D
Liver; 2000 Feb; 20(1):88-92. PubMed ID: 10726965
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
20. A quantitative study on vascular angiotensin II receptors in rats with portal hypertension.
Li J; Dai Z; Cui W; Hu Y
J Tongji Med Univ; 1997; 17(4):235-8. PubMed ID: 9812788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
